Eversana Life Science Services LLC
Milwaukee, WI
- UEI
- LG9CFPBP9188
- CAGE
- 7Q383
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 190 N Milwaukee St, Milwaukee, WI 53202, USA
- Website
- eversana.com
- Employees
- 1K-5K
- Estimated annual revenue
- $1B-$10B
- Industry
-
- Industrials
- Commercial & Professional Services
- Professional Services
- Consulting
- SIC code
- 89 Services, Not Elsewhere Classified
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $230,476 |
| FY2025 | $0 |
| FY2024 | $1,520,250 |
| FY2023 | $71,891 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Justice | $230,476 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mckesson Plasma And Biologics LLC | Shepherdsville, KY | 325412 Pharmaceutical Preparation Manufacturing |
| Pantherx Specialty Pharmacy | Pittsburgh, PA | 456110 Pharmacies and Drug Retailers |
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
| CSL Behring L.L.C. | King of Prussia, PA | 325412 Pharmaceutical Preparation Manufacturing |
| Cardinal Health Specialty Pharmaceutical Distribution | Dublin, OH | 424210 Drugs and Druggists' Sundries Merchant Wholesalers |
About the company
Eversana Life Science Services LLC, a for-profit limited liability company based in Milwaukee, Wisconsin, supplies specialty pharmaceutical products to federal healthcare facilities and research institutions as a prime contractor, operating exclusively in the open market with no set-aside designations across its 27 recent awards.
Eversana's federal footprint centers on specialty pharmaceutical distribution. The vendor holds two definitive contracts with the National Center for Advancing Translational Sciences (NIH) — a $874,750 contract awarded September 2024 and a $645,500 contract awarded May 2024 — for supply of specialty medications including Prolastin-C, Thiopronin, and Ferriprox. Recurring federal customers place monthly purchase orders through the Federal Medical Center Rochester (Bureau of Prisons) for Elfabrio (vestronidase alfa-vjbk) medication, with eight orders issued between January and July 2026, each valued at approximately $27,000. Veterans Integrated Service Network 21 generated a sustained stream of purchase orders from 2022 through 2023 for Prolastin-C and Thiopronin, ranging from $10,700 to $21,830 per order.
Customer concentration follows a bimodal distribution split between volume and value. The National Center for Advancing Translational Sciences anchors 75% of combined potential value ($1.5 million of $2 million total) across just two awards, while the Federal Medical Center Rochester drives half of recent award volume (9 awards, $230 thousand combined value) through monthly repeat purchase orders. Veterans Integrated Service Network 21 accounts for 52% of award count (14 awards) but only 9% of potential value ($183 thousand), reflecting the small-ticket nature of routine pharmaceutical supply orders. Three Veterans Health Administration facilities and the NIH National Center for Advancing Translational Sciences comprise the entire customer set.
The vendor's NAICS footprint aligns with its product distribution model: 16 awards cite Pharmaceutical Preparation Manufacturing (NAICS 325412), nine cite Drugs and Druggists' Sundries Merchant Wholesalers (NAICS 424210), and two cite consulting services. All 24 PSC-coded awards fall under Drugs and Biologicals (PSC 6505).
Activity shows sharp concentration in 2022, when 12 of 27 awards were issued (primarily VISN 21 purchase orders), with recent calendar-year 2026 activity returning to 9 awards after relative dormancy in 2023–2024. Awards have obligated 100% of combined potential value; the vendor reports no outstanding recompete exposure because most purchase orders complete within thirty to ninety days of award. SCI reporting covers only two definitive contracts exceeding the $150,000 threshold, showing $991 thousand in invoiced revenue across 2.0 FTEs in FY2024 and $0 in FY2025; this represents a partial view of federal pharmaceutical sales and excludes goods-based purchase orders and sub-million contract work dominating the award portfolio. Across the two SCI-reportable prime records, median government-paid labor rates ran $245.84 per hour, with ranges from $229.73 to $261.96 per hour. The vendor operates as a 100% prime contractor with no subcontractor engagement.
Quick answers
Is Eversana Life Science Services LLC registered in SAM.gov?
Yes. Eversana Life Science Services LLC's SAM.gov registration is active through June 29, 2027.
How much has Eversana Life Science Services LLC received in federal contracts?
Federal contracts obligated $1,822,617 to Eversana Life Science Services LLC in fiscal years 2023 through 2027.
What is Eversana Life Science Services LLC's most recent federal award?
Eversana Life Science Services LLC's most recent federal contract award is FY26 B1 eversana medication - elfabrio SEP 26 (15B41226P00000191), from Federal Medical Center Rochester (BOP), on July 21, 2026.
On GovTribe
See Eversana Life Science Services LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors